课题基金 / 基金详情

Regulation of Nucleoside Transporters by Protein Kinases

Regulation of Nucleoside Transporters by Protein Kinases
蛋白激酶对核苷转运蛋白的调节
批准号:
6924531
负责人:
Lee M Graves
金额:
$29.09万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2008-07-31

项目摘要

项目成果

Lee M Graves的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):平衡的核苷转运体是对核苷和化疗核苷类似物(例如Ara-C、吉西他滨)的摄取至关重要的完整的膜蛋白。在联合化疗(即顺铂、放疗)后,已经观察到对核苷类似物的敏感性增加,尽管对这些作用的机制(S)尚不清楚。平衡的核苷转运蛋白(ENT1/2)普遍表达,并根据细胞对有丝分裂原或应激信号的暴露而受到不同的调节。目前,控制这些转运蛋白转录调控的分子事件尚不清楚。我们实验室一直在研究蛋白激酶对嘧啶核苷酸合成的调控。我们最近的研究集中在核苷的摄取和嘧啶核苷酸的残存合成中对ENT1/2的需求。具体地说,我们的研究指出了Src和应激激活的c-jun激酶(JNK)在ENT1/2表达调控中的关键作用。因此,本研究的目的是确定ENT1/2转录调控所必需的依赖于激酶的信号,并确定这一事件对细胞增殖或存活的影响。此外,我们还将确定激酶介导的ENT1/2表达调控所需的启动子元件。最后,我们将研究JNK的激活是否参与了细胞对核苷类似物的上调和增敏。这项建议的具体目标是: 目的#1.确定特异性蛋白激酶参与调节ENT1/2的表达。 目的#2.阐明ENT1和ENT2表达所需的启动子元件。 目的#3.研究Ents在生长、分化和化疗增敏中的特殊作用。
英文摘要
DESCRIPTION (provided by applicant): The equilibrative nucleoside transporters are integral membrane proteins that are essential for the uptake of nucleosides and chemotherapeutic nucleoside analogs (e.g. Ara-C, gemcitabine). Enhanced sensitivity to nucleoside analogs has been observed after combined chemotherapy (i.e. cisplatinum, irradiation), although the mechanism(s) responsible for these effects are poorly understood. The equilibrative nucleoside transporters (ENT1/2) are ubiquitously expressed and are differentially regulated depending on the exposure of cells to mitogens or stress signals. At present, the molecular events that control the transcriptional regulation of these transporters are unknown. Our lab has been investigating the regulation of pyrimidine nucleotide synthesis by protein kinases. Our recent studies have focused on the requirement of ENT 1/2 in the uptake of nucleoside and the salvage synthesis of pyrimidine nucleotides. Specifically our studies have pointed to a crucial role for Src and the stress-activated c-Jun kinases (JNK) in the regulation of ENT1/2 expression. Thus the objective of this proposal is to characterize the kinase-dependent signals that are necessary for the transcriptional regulation of ENT 1/2, and to determine the impact of this event on cell proliferation or survival. In addition, we will determine the promoter elements that are required for kinase-mediated regulation of ENT1/2 expression. Finally, we will investigate whether activation of JNK is involved in the up-regulation and enhanced sensitization of cells to nucleoside analogs. The Specific Aims of the proposal are: Aim #1. Determine the involvement of specific protein kinases in the regulation of ENT1/2 expression. Aim #2. Elucidate the promoter elements necessary for the expression of ENT1 and ENT2. Aim #3. Examine the specific roles of ENTs in growth, differentiation and chemosensitization .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
Tumor subtypes and therapy response in pancreatic cancer
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: